Research from The Commonwealth Fund found little indication that risk segmentation is causing adverse effects in the insurance market either in coverage sold on the exchanges and coverage sold off the exchanges.
Pharmacy cost trends are expected to increase 10% up from 6.3% the year before, with specialty pharmacy trends experiencing the largest increases, according to a survey from Aon Health.
Although the fee-for-service model of reimbursement has been blamed as an reason for high healthcare costs in America, a report from HealthPocket found that eliminating this payment model in provider-owned health plans did not produce the cheapest health plans.
In Texas, a new law will allow more patients to get help negotiating lower bills from hospital-based doctors who are out of network instead of being stuck with huge bills even when the hospital is in their health insurer's provider network.
Top managed care news this week included results for accountable care organizations during 2014, avoiding delays in cancer diagnosis with the use of an electronic health record trigger, and 3 studies look at colorectal cancer screening.
Both ExpressScripts and CVS Health say the new class of cholesterol-fighting drugs will be generally unavailable until their P&T committees complete evaluations, and negotiations for discounts or exclusive deals occur.
The study published in JNCI has identified CES2 expression as a predictor of response to FOLFIRINOX.
In the second quarter of 2015 the healthcare spending growth rate was 5.9%, a decline from 6.6% in the first quarter of the year, but the health spending growth rate is still 2 percentage points higher than rates experienced between 2009 and 2013.